Rare Disease Business Manager, Narcolepsy Type 1 – Sleep Disorders
Is this job for you?
Build my CV Build your CV and see how well you match this role — and every other one.
Track your applications on mobile The free Whileresume app, on iPhone and Android.
The role
Drive sales growth and territory expansion for a rare neurological sleep disorder, narcolepsy type 1.
Educate and engage healthcare professionals on disease state, orexin biology, and approved therapies to generate informed demand.
Execute post-approval launch plans, align with cross-functional teams, and leverage approved materials to meet quarterly and annual sales goals.
Build and sustain strategic relationships with sleep specialists, neurologists, pulmonologists, and sleep centers to enhance diagnosis and treatment access.
Apply data-driven insights for territory planning, account prioritization, and tailored regional strategies while managing payer considerations.
Collaborate with Patient Access, Market Access, Marketing, and Sales to drive compliance, training, and high-quality customer service while managing budget and travel.
Educate and engage healthcare professionals on disease state, orexin biology, and approved therapies to generate informed demand.
Execute post-approval launch plans, align with cross-functional teams, and leverage approved materials to meet quarterly and annual sales goals.
Build and sustain strategic relationships with sleep specialists, neurologists, pulmonologists, and sleep centers to enhance diagnosis and treatment access.
Apply data-driven insights for territory planning, account prioritization, and tailored regional strategies while managing payer considerations.
Collaborate with Patient Access, Market Access, Marketing, and Sales to drive compliance, training, and high-quality customer service while managing budget and travel.
See the full job post
Responsibilities, requirements, skills and benefits — create your free account.
or
Already have an account?
Log inYou might also like these jobs
No closely matching jobs yet — here are the most recent ones.